Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 3
1988 6
1989 10
1990 6
1991 12
1992 11
1993 18
1994 13
1995 22
1996 30
1997 35
1998 41
1999 41
2000 53
2001 57
2002 44
2003 39
2004 57
2005 60
2006 83
2007 71
2008 75
2009 80
2010 99
2011 93
2012 109
2013 144
2014 159
2015 196
2016 186
2017 193
2018 222
2019 204
2020 231
2021 279
2022 244
2023 206

Text availability

Article attribute

Article type

Publication date

Search Results

3,034 results

Results by year

Citations

4 articles found by citation matching
Show all

Search results

Filters applied: . Clear all
Page 1
The neuropathological diagnosis of Alzheimer's disease.
DeTure MA, Dickson DW. DeTure MA, et al. Mol Neurodegener. 2019 Aug 2;14(1):32. doi: 10.1186/s13024-019-0333-5. Mol Neurodegener. 2019. PMID: 31375134 Free PMC article. Review.
Alzheimer's disease is the most common cause of dementia globally. ...Other disease processes that are frequent, but not inevitable, are also discussed, including pathologic processes that can clinically mimic Alzheimer's disease. …
Alzheimer's disease is the most common cause of dementia globally. ...Other disease processes that are frequent, …
The neuroimmune axis of Alzheimer's disease.
Jorfi M, Maaser-Hecker A, Tanzi RE. Jorfi M, et al. Genome Med. 2023 Jan 26;15(1):6. doi: 10.1186/s13073-023-01155-w. Genome Med. 2023. PMID: 36703235 Free PMC article. Review.
Alzheimer's disease (AD) is a genetically complex and heterogeneous disorder with multifaceted neuropathological features, including beta-amyloid plaques, neurofibrillary tangles, and neuroinflammation. ...These findings support a neuroimmune axis of A …
Alzheimer's disease (AD) is a genetically complex and heterogeneous disorder with multifaceted neuropathological …
Aging, Cellular Senescence, and Alzheimer's Disease.
Liu RM. Liu RM. Int J Mol Sci. 2022 Feb 11;23(4):1989. doi: 10.3390/ijms23041989. Int J Mol Sci. 2022. PMID: 35216123 Free PMC article. Review.
Aging is the greatest risk factor for late-onset Alzheimer's disease (LOAD), which accounts for >95% of Alzheimer's disease (AD) cases. ...Senescent astrocytes, microglia, endothelial cells, and neurons have been detected in the brain …
Aging is the greatest risk factor for late-onset Alzheimer's disease (LOAD), which accounts for >95% of Alzheimer …
Animal models of Alzheimer's disease: Applications, evaluation, and perspectives.
Chen ZY, Zhang Y. Chen ZY, et al. Zool Res. 2022 Nov 18;43(6):1026-1040. doi: 10.24272/j.issn.2095-8137.2022.289. Zool Res. 2022. PMID: 36317468 Free PMC article. Review.
Although great advances in elucidating the molecular basis and pathogenesis of Alzheimer's disease (AD) have been made and multifarious novel therapeutic approaches have been developed, AD remains an incurable disease. ...Most AD research focuses on ea …
Although great advances in elucidating the molecular basis and pathogenesis of Alzheimer's disease (AD) have been made …
Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
Thal DR, Walter J, Saido TC, Fändrich M. Thal DR, et al. Acta Neuropathol. 2015 Feb;129(2):167-82. doi: 10.1007/s00401-014-1375-y. Epub 2014 Dec 23. Acta Neuropathol. 2015. PMID: 25534025 Review.
Alzheimer's disease (AD) is characterized by beta-amyloid plaques and intraneuronal tau aggregation usually associated with cerebral amyloid angiopathy (CAA). ...Thus, the inhibition of Abeta aggregation and maturation before entering the symptomatic stage of …
Alzheimer's disease (AD) is characterized by beta-amyloid plaques and intraneuronal tau aggregation usually associated …
Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review.
Serý O, Povová J, Míšek I, Pešák L, Janout V. Serý O, et al. Folia Neuropathol. 2013;51(1):1-9. doi: 10.5114/fn.2013.34190. Folia Neuropathol. 2013. PMID: 23553131 Free article. Review.
More than 100 years after description of Alzheimer's disease (AD), two major pathological processes observed already by Alois Alzheimer, remain as the main explanation of the pathogenesis of Alzheimer's disease. ...Promising explan …
More than 100 years after description of Alzheimer's disease (AD), two major pathological processes observed already by …
Epigenetics of Alzheimer's Disease.
Nikolac Perkovic M, Videtic Paska A, Konjevod M, Kouter K, Svob Strac D, Nedic Erjavec G, Pivac N. Nikolac Perkovic M, et al. Biomolecules. 2021 Jan 30;11(2):195. doi: 10.3390/biom11020195. Biomolecules. 2021. PMID: 33573255 Free PMC article. Review.
There are currently no validated biomarkers which can be used to accurately diagnose Alzheimer's disease (AD) or to distinguish it from other dementia-causing neuropathologies. ...
There are currently no validated biomarkers which can be used to accurately diagnose Alzheimer's disease (AD) or to dis …
Early- and late-onset Alzheimer disease: Are they the same entity?
Tellechea P, Pujol N, Esteve-Belloch P, Echeveste B, García-Eulate MR, Arbizu J, Riverol M. Tellechea P, et al. Neurologia (Engl Ed). 2018 May;33(4):244-253. doi: 10.1016/j.nrl.2015.08.002. Epub 2015 Nov 3. Neurologia (Engl Ed). 2018. PMID: 26546285 Free article. Review. English, Spanish.
Early-onset Alzheimer disease (EOAD), which presents in patients younger than 65 years, has frequently been described as having different features from those of late-onset Alzheimer disease (LOAD). ...Fundamentally, the onset of EOAD is more likely to …
Early-onset Alzheimer disease (EOAD), which presents in patients younger than 65 years, has frequently been described as havin …
The neuropathology of chronic traumatic encephalopathy.
McKee AC, Stein TD, Kiernan PT, Alvarez VE. McKee AC, et al. Brain Pathol. 2015 May;25(3):350-64. doi: 10.1111/bpa.12248. Brain Pathol. 2015. PMID: 25904048 Free PMC article. Review.
Given the importance of sports participation and physical exercise to physical and psychological health as well as disease resilience, it is critical to identify the genetic risk factors for CTE as well as to understand how other variables, such as stress, age at ex …
Given the importance of sports participation and physical exercise to physical and psychological health as well as disease resilience …
Anxiety and Alzheimer's disease: Behavioral analysis and neural basis in rodent models of Alzheimer's-related neuropathology.
Pentkowski NS, Rogge-Obando KK, Donaldson TN, Bouquin SJ, Clark BJ. Pentkowski NS, et al. Neurosci Biobehav Rev. 2021 Aug;127:647-658. doi: 10.1016/j.neubiorev.2021.05.005. Epub 2021 May 9. Neurosci Biobehav Rev. 2021. PMID: 33979573 Free PMC article. Review.
Alzheimer's disease (AD) pathology is commonly associated with cognitive decline but is also composed of neuropsychiatric symptoms including psychological distress and alterations in mood, including anxiety and depression. ...We conclude by discussing putativ …
Alzheimer's disease (AD) pathology is commonly associated with cognitive decline but is also composed of neuropsychiatr …
3,034 results